Re:Moderna Covid vaccine candidate almost 95% effective, tri...
by tooltalk on Monday November 16, 2020 @11:41AM
(#25113737)
Reading your source, it seems the bureaucratic limitation was their #1; then comes politics.
"Pfizer declined the R&D funding in order to "liberate" scientists from bureaucratic limitations as they worked to develop a COVID-19 vaccine, the pharmaceutical company's CEO, Dr. Albert Bourla, said in a September interview with CBS News' Margaret Brennan."
> "When you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports," he finished. "And also, I wanted to keep Pfizer out of politics, by the way."
https://www.newsweek.com/pfizer-avoided-rd-funding-trumps-op...